Pralatrexate for Relapsed or Refractory Peripheral T-cell Lymphoma (Q64807995)
Jump to navigation
Jump to search
clinical trial
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Pralatrexate for Relapsed or Refractory Peripheral T-cell Lymphoma |
clinical trial |
Statements
Pralatrexate for Relapsed or Refractory Peripheral T-cell Lymphoma: a Multicenter, Multinational Retrospective Analysis (English)
0 references
23 September 2016
0 references
30 June 2017
0 references
33
0 references
18 year
0 references